The US Food and Drug Administration has cleared French drugmaker Sanofi-Aventis and USA-based Procter & Gamble Pharmaceuticals' Actonel with Calcium (risedronate sodium/calcium carbonate), which is designed to provide the fracture protection of its predecessor but with the added benefit of conveniently-packaged calcium tablets.